| Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders. | |
| | |
MedLine Citation:
|
PMID: 21545189 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background: When guidelines for health economic evaluations prescribe that a societal perspective should be adopted, productivity costs should be included. However, previous research suggests that, in practice, productivity costs are often neglected. This may considerably bias the results of cost-effectiveness studies, particularly those regarding treatments targeted at diseases with a high incidence rate in the working population, such as depressive disorders. Objectives: This study aimed to, first, investigate whether economic evaluations of treatments for depressive disorders include productivity costs and, if so, how. Second, to investigate how the inclusion or exclusion of productivity costs affects incremental costs. Methods: A systematic literature review was performed. Included articles were reviewed to determine (i) whether productivity costs had been included and (ii) whether the studies adhered to national health economic guidelines about the inclusion or exclusion of these costs. For those studies that did include productivity costs, we calculated what proportion of total costs were productivity costs. Subsequently, the incremental costs, excluding productivity costs, were calculated and compared with the incremental costs presented in the original article, to analyse the impact of productivity costs on final results. Regression analyses were used to investigate the relationship between the level of productivity costs and the type of depressive disorder, the type of treatment and study characteristics such as time horizon used and productivity cost valuation method. Results: A total of 81 unique economic evaluations of treatments for adults with depressive disorders were identified, 24 of which included productivity costs in the numerator and one in the denominator. Approximately 69% of the economic evaluations ignored productivity costs. Two-thirds of the studies complied with national guidelines regarding the inclusion of productivity costs. For the studies that included productivity costs, these costs reflected an average of 60% of total costs per treatment arm. The inclusion or exclusion of productivity costs substantially affected incremental costs in a number of studies. Regression analyses showed that the level of productivity costs was significantly associated with study characteristics such as average age, the methods of data collection regarding work time lost, the values attached to lost work time, the type of depressive disorder, the type of treatment provided and the level of direct costs. Conclusions: Studies that do not include productivity costs may, in many cases, poorly reflect full societal costs (or savings) of an intervention. Furthermore, when comparing total costs reported in studies that include productivity costs, it should be noted that study characteristics such as the methods used to assess productivity costs may affect their level. |
| | |
Authors:
|
Marieke Krol; Jocé Papenburg; Marc Koopmanschap; Werner Brouwer |
Related Documents
:
|
9872099 - Financing college education. 1199849 - Abortion attitudes among catholic college students. 8333829 - Components of assertiveness: their relationships with assertive rights and depressed mo... 17429149 - Undergraduate college students' upper extremity symptoms and functional limitations rel... 20378879 - Student perspectives on animal-welfare education in american veterinary medical curricula. 17127539 - College binge drinking: deviant versus mainstream behavior. 11736849 - John flynn scholarship students: case studies of useful contributions to remote health ... 17506149 - Ethnic composition of schools affects episodic heavy drinking only in ethnic-minority s... 19058249 - Maintaining competence in the field: learning about practice, through practice, in prac... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-5-5 |
Journal Detail:
|
Title: PharmacoEconomics Volume: - ISSN: 1179-2027 ISO Abbreviation: - Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-5-6 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9212404 Medline TA: Pharmacoeconomics Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A conformational role for the C-terminal tail of the intrinsically disordered High Mobility Group A ...
Next Document: Ultrasound-Guided Injection of a Corticosteroid and Hyaluronic Acid: A Potential New Approach to the...